vs
Ardmore Shipping Corp（ASC）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Tarsus Pharmaceuticals, Inc.的季度营收约是Ardmore Shipping Corp的1.9倍（$151.7M vs $81.2M），Ardmore Shipping Corp净利率更高（15.7% vs -5.5%，领先21.3%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs -15.5%），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs -6.0%）
阿德莫尔航运是一家全球化海上运输企业，持有并运营中型成品油轮与化学品运输船队，可为全球能源、化工及贸易领域客户提供石油产品、特种化学品及其他散装液态货物的海运服务。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
ASC vs TARS — 直观对比
营收规模更大
TARS
是对方的1.9倍
$81.2M
营收增速更快
TARS
高出143.9%
-15.5%
净利率更高
ASC
高出21.3%
-5.5%
两年增速更快
TARS
近两年复合增速
-6.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $151.7M |
| 净利润 | $12.8M | $-8.4M |
| 毛利率 | — | — |
| 营业利润率 | 16.1% | -5.3% |
| 净利率 | 15.7% | -5.5% |
| 营收同比 | -15.5% | 128.4% |
| 净利润同比 | -47.0% | 63.8% |
| 每股收益（稀释后） | $0.30 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASCTARS
| Q4 25 | — | $151.7M | ||
| Q3 25 | $81.2M | $118.7M | ||
| Q2 25 | $72.0M | $102.7M | ||
| Q1 25 | $74.0M | $78.3M | ||
| Q4 24 | — | $66.4M | ||
| Q3 24 | $96.1M | $48.1M | ||
| Q2 24 | $121.3M | $40.8M | ||
| Q1 24 | $106.3M | $27.6M |
净利润ASCTARS
| Q4 25 | — | $-8.4M | ||
| Q3 25 | $12.8M | $-12.6M | ||
| Q2 25 | $9.6M | $-20.3M | ||
| Q1 25 | $6.3M | $-25.1M | ||
| Q4 24 | — | $-23.1M | ||
| Q3 24 | $24.1M | $-23.4M | ||
| Q2 24 | $62.7M | $-33.3M | ||
| Q1 24 | $39.2M | $-35.7M |
营业利润率ASCTARS
| Q4 25 | — | -5.3% | ||
| Q3 25 | 16.1% | -12.2% | ||
| Q2 25 | 13.5% | -21.6% | ||
| Q1 25 | 8.6% | -33.5% | ||
| Q4 24 | — | -36.8% | ||
| Q3 24 | 25.4% | -52.3% | ||
| Q2 24 | 51.3% | -81.6% | ||
| Q1 24 | 37.2% | -136.5% |
净利率ASCTARS
| Q4 25 | — | -5.5% | ||
| Q3 25 | 15.7% | -10.6% | ||
| Q2 25 | 13.3% | -19.8% | ||
| Q1 25 | 8.5% | -32.1% | ||
| Q4 24 | — | -34.8% | ||
| Q3 24 | 25.1% | -48.7% | ||
| Q2 24 | 51.7% | -81.6% | ||
| Q1 24 | 36.9% | -129.4% |
每股收益（稀释后）ASCTARS
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $0.30 | $-0.30 | ||
| Q2 25 | $0.22 | $-0.48 | ||
| Q1 25 | $0.14 | $-0.64 | ||
| Q4 24 | — | $-0.57 | ||
| Q3 24 | $0.55 | $-0.61 | ||
| Q2 24 | $1.47 | $-0.88 | ||
| Q1 24 | $0.92 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $417.3M |
| 总债务越低越好 | $116.1M | $72.4M |
| 股东权益账面价值 | $628.2M | $343.4M |
| 总资产 | $799.8M | $562.2M |
| 负债/权益比越低杠杆越低 | 0.18× | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资ASCTARS
| Q4 25 | — | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | — | $381.1M | ||
| Q1 25 | — | $407.9M | ||
| Q4 24 | — | $291.4M | ||
| Q3 24 | — | $317.0M | ||
| Q2 24 | — | $323.6M | ||
| Q1 24 | — | $298.5M |
总债务ASCTARS
| Q4 25 | — | $72.4M | ||
| Q3 25 | $116.1M | $72.3M | ||
| Q2 25 | $25.0M | $72.1M | ||
| Q1 25 | $20.5M | $72.0M | ||
| Q4 24 | — | $71.8M | ||
| Q3 24 | $22.5M | $71.7M | ||
| Q2 24 | $44.2M | $71.6M | ||
| Q1 24 | $23.1M | $29.9M |
股东权益ASCTARS
| Q4 25 | — | $343.4M | ||
| Q3 25 | $628.2M | $335.1M | ||
| Q2 25 | $618.3M | $332.6M | ||
| Q1 25 | $610.7M | $342.5M | ||
| Q4 24 | — | $224.5M | ||
| Q3 24 | $627.0M | $237.5M | ||
| Q2 24 | $617.7M | $252.2M | ||
| Q1 24 | $567.9M | $275.2M |
总资产ASCTARS
| Q4 25 | — | $562.2M | ||
| Q3 25 | $799.8M | $534.6M | ||
| Q2 25 | $703.8M | $495.0M | ||
| Q1 25 | $690.4M | $500.8M | ||
| Q4 24 | — | $377.0M | ||
| Q3 24 | $722.8M | $376.3M | ||
| Q2 24 | $742.0M | $376.8M | ||
| Q1 24 | $704.1M | $349.3M |
负债/权益比ASCTARS
| Q4 25 | — | 0.21× | ||
| Q3 25 | 0.18× | 0.22× | ||
| Q2 25 | 0.04× | 0.22× | ||
| Q1 25 | 0.03× | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | 0.04× | 0.30× | ||
| Q2 24 | 0.07× | 0.28× | ||
| Q1 24 | 0.04× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.9M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | — | $13.0M |
| 自由现金流率自由现金流/营收 | — | 8.6% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.3M |
8季度趋势，按日历期对齐
经营现金流ASCTARS
| Q4 25 | — | $19.3M | ||
| Q3 25 | $17.9M | $18.3M | ||
| Q2 25 | $11.2M | $-29.4M | ||
| Q1 25 | $26.3M | $-20.7M | ||
| Q4 24 | — | $-22.2M | ||
| Q3 24 | $39.9M | $-8.7M | ||
| Q2 24 | $48.4M | $-14.4M | ||
| Q1 24 | $49.2M | $-37.8M |
自由现金流ASCTARS
| Q4 25 | — | $13.0M | ||
| Q3 25 | — | $16.3M | ||
| Q2 25 | — | $-30.4M | ||
| Q1 25 | — | $-21.2M | ||
| Q4 24 | — | $-22.3M | ||
| Q3 24 | — | $-8.9M | ||
| Q2 24 | — | $-15.4M | ||
| Q1 24 | — | $-38.0M |
自由现金流率ASCTARS
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -27.1% | ||
| Q4 24 | — | -33.5% | ||
| Q3 24 | — | -18.6% | ||
| Q2 24 | — | -37.8% | ||
| Q1 24 | — | -137.5% |
资本支出强度ASCTARS
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 0.6% |
现金转化率ASCTARS
| Q4 25 | — | — | ||
| Q3 25 | 1.40× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 4.20× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
